DK0448191T3 - 1,4,7,10-tetraazacyklododecan-butyltrioler, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende disse - Google Patents
1,4,7,10-tetraazacyklododecan-butyltrioler, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende disseInfo
- Publication number
- DK0448191T3 DK0448191T3 DK91250081.6T DK91250081T DK0448191T3 DK 0448191 T3 DK0448191 T3 DK 0448191T3 DK 91250081 T DK91250081 T DK 91250081T DK 0448191 T3 DK0448191 T3 DK 0448191T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical agents
- tetraazacyclododecan
- triols
- butyl
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4009119A DE4009119A1 (de) | 1990-03-19 | 1990-03-19 | 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0448191T3 true DK0448191T3 (da) | 1995-11-20 |
Family
ID=6402765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91250081.6T DK0448191T3 (da) | 1990-03-19 | 1991-03-18 | 1,4,7,10-tetraazacyklododecan-butyltrioler, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende disse |
Country Status (17)
Country | Link |
---|---|
US (4) | US5980864A (fr) |
EP (1) | EP0448191B1 (fr) |
JP (1) | JP2968367B2 (fr) |
AT (1) | ATE124405T1 (fr) |
AU (1) | AU647091B2 (fr) |
CA (1) | CA2038493C (fr) |
DE (3) | DE4009119A1 (fr) |
DK (1) | DK0448191T3 (fr) |
ES (1) | ES2074219T3 (fr) |
FI (1) | FI109695B (fr) |
HK (1) | HK1002811A1 (fr) |
HU (1) | HU215964B (fr) |
IE (1) | IE67643B1 (fr) |
IL (1) | IL97592A (fr) |
NO (2) | NO179610C (fr) |
NZ (1) | NZ237461A (fr) |
PT (1) | PT97065B (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362476A (en) * | 1984-10-18 | 1994-11-08 | Board Of Regents, The University Of Texas System | Alkyl phosphonate polyazamacrocyclic cheates for MRI |
US5316757A (en) * | 1984-10-18 | 1994-05-31 | Board Of Regents, The University Of Texas System | Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups |
DE4035760A1 (de) * | 1990-11-08 | 1992-05-14 | Schering Ag | Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
DE4237943C2 (de) * | 1992-11-06 | 1997-10-23 | Schering Ag | Verfahren zur Herstellung von Metallkomplexen der N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- und N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivate |
DE4140779A1 (de) * | 1991-12-06 | 1993-06-09 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Verfahren zur herstellung von mono-n-substituierten tetraazamakrocyclen |
DE4218744C2 (de) * | 1992-06-04 | 1997-11-06 | Schering Ag | Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe |
DE4317588C2 (de) * | 1993-05-24 | 1998-04-16 | Schering Ag | Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung |
DE4318369C1 (de) * | 1993-05-28 | 1995-02-09 | Schering Ag | Verwendung von makrocyclischen Metallkomplexen als Temperatursonden |
US5874573A (en) * | 1995-06-26 | 1999-02-23 | Concat, Inc. | Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy |
DE19646762B4 (de) * | 1996-11-04 | 2004-05-13 | Schering Ag | Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren |
DE19652387A1 (de) * | 1996-12-04 | 1998-06-10 | Schering Ag | Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung |
US20050187126A1 (en) * | 2002-08-27 | 2005-08-25 | Busch Daryle H. | Catalysts and methods for catalytic oxidation |
ZA981883B (en) * | 1997-03-07 | 1998-09-01 | Univ Kansas | Catalysts and methods for catalytic oxidation |
US20030017941A1 (en) * | 1997-03-07 | 2003-01-23 | The Procter & Gamble Company | Catalysts and methods for catalytic oxidation |
US20080125344A1 (en) * | 2006-11-28 | 2008-05-29 | Daryle Hadley Busch | Bleach compositions |
HU226087B1 (en) | 1997-03-07 | 2008-04-28 | Procter & Gamble | Laundry and cleaning compositions containing bleach catalyst |
DE19724186C2 (de) * | 1997-06-02 | 2002-07-18 | Schering Ag | Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe |
IT1297035B1 (it) | 1997-12-30 | 1999-08-03 | Bracco Spa | Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico |
DE19816370B4 (de) * | 1998-04-03 | 2004-09-09 | Schering Ag | Substituierte Mangan-D02A-Komplexe, diese enthaltende diagnostische Mittel und ihre Verwendung |
EP1088559A3 (fr) * | 1999-09-29 | 2002-10-02 | INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN | Formulations galéniques |
DE10064467C2 (de) * | 2000-12-15 | 2002-10-31 | Schering Ag | Lithium-Komplexe von N-(1-Hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren Herstellung und Verwendung |
US7011816B2 (en) * | 2001-12-26 | 2006-03-14 | Immunomedics, Inc. | Labeling targeting agents with gallium-68 and gallium-67 |
WO2004006934A2 (fr) * | 2002-07-10 | 2004-01-22 | Hans Robert Kalbitzer | Procede et composes pour modifier la structure tridimensionnelle de proteines gnb |
US20040048763A1 (en) * | 2002-08-27 | 2004-03-11 | The Procter & Gamble Co. | Bleach compositions |
US20060239913A1 (en) * | 2003-06-25 | 2006-10-26 | Marc Port | Peptide conjugate for magnetic resonance imaging |
FR2867473B1 (fr) | 2004-03-12 | 2006-06-23 | Guerbet Sa | Compose de porphyrines et utilisation a haut champ en irm |
CN1993357B (zh) * | 2004-07-02 | 2011-10-19 | 伯拉考成像股份公司 | 用于磁共振成像(mri)的含有具有多羟基化取代基的螯合部分的高弛豫造影剂 |
DE102009053171B4 (de) | 2009-11-04 | 2011-07-21 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol) |
DE102009057274B4 (de) | 2009-12-02 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung mittels Trioxobicyclo-octan |
WO2011054480A1 (fr) | 2009-11-09 | 2011-05-12 | Bayer Schering Pharma Aktiengesellschaft | Préparation de gadobutrol au moyen d'une membrane céramique |
EP2327395A1 (fr) | 2009-11-23 | 2011-06-01 | Bracco Imaging S.p.A | Procédé de préparation d'un complexe de gadobénate et de diméglumine sous forme solide |
DE102010013833A1 (de) | 2010-03-29 | 2011-09-29 | Bayer Schering Pharma Aktiengesellschaft | Herstellung von Gadobutrol mittels Dimethylformamiddimethylacetal |
DE102010023105A1 (de) | 2010-06-04 | 2011-12-08 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol |
EP2457594A1 (fr) | 2010-11-05 | 2012-05-30 | Bracco Imaging S.p.A | Système CEST démontrant une réactivité indépendante de la concentration |
RS60001B1 (sr) | 2011-04-21 | 2020-04-30 | Bayer Ip Gmbh | Pripremanje gadobutrola visoke čistoće |
US10781188B2 (en) | 2015-12-10 | 2020-09-22 | Bracco Imaging S.P.A. | Contrast agents |
ES2932302T3 (es) | 2015-12-10 | 2023-01-17 | Bracco Imaging Spa | Agentes de contraste diméricos |
US11007283B2 (en) * | 2016-04-13 | 2021-05-18 | Bracco Imaging S.P.A. | Contrast agents |
PL3519394T3 (pl) | 2016-09-27 | 2020-11-30 | Bayer Pharma Aktiengesellschaft | Sposób wytwarzania krystalicznej postaci o modyfikacji a kalkobutrolu |
WO2018069179A1 (fr) | 2016-10-12 | 2018-04-19 | T2Pharma Gmbh | Procédé de préparation de formulations de complexes métalliques de lanthanide de chélates macrocycliques |
WO2018069176A1 (fr) | 2016-10-12 | 2018-04-19 | T2Pharma Gmbh | Procédé de préparation de formulations de complexes métalliques lanthanides de chélates macrocycliques |
ES2899033T3 (es) | 2016-12-12 | 2022-03-09 | Bracco Imaging Spa | Agentes de contraste diméricos |
EP3392254A1 (fr) * | 2017-04-20 | 2018-10-24 | Koninklijke Philips N.V. | Composés à utiliser dans le diagnostic d'une maladie |
KR101971435B1 (ko) | 2017-08-29 | 2019-04-24 | 주식회사 엔지켐생명과학 | 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법 |
EP3820853A4 (fr) | 2018-07-10 | 2022-08-17 | Biophore India Pharmaceuticals Pvt. Ltd. | Procédé de préparation d'acide 2,2',2''-(10-((2r,3s)-1,3,4-trihydroxy butan-2-yl)-1,4,7,10-tétraazacyclododécane-1,4,7-triyl) triacétique et de ses complexes |
KR102167614B1 (ko) * | 2018-08-23 | 2020-10-19 | 에스티팜 주식회사 | 가도부트롤의 제조방법 |
CN114573521B (zh) * | 2020-12-01 | 2023-10-27 | 威智医药股份有限公司 | 一种钆布醇及其中间体的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1491129A (en) * | 1975-06-04 | 1977-11-09 | Guerbet Sa | Iodo-benzene derivatives and an x-ray contrast medium containing them |
US4284620A (en) * | 1979-03-23 | 1981-08-18 | Mallinckrodt, Inc. | N-(2-Hydroxyethyl)-2,4,6-triiodo-3,5-bis-(2-keto-L-gulonamido)benzamide and radiological compositions containing same |
NO161560C (no) * | 1980-04-17 | 1989-09-06 | Univ California | Symmetriske trijodisoftaldiamid-derivater og roentgenkontrastmidler inneholdende disse. |
DE3150916A1 (de) * | 1981-12-18 | 1983-06-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel" |
US5059412A (en) * | 1984-06-04 | 1991-10-22 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
MX174467B (es) * | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos |
US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
DE3625417C2 (de) * | 1986-07-28 | 1998-10-08 | Schering Ag | Tetraazacyclododecan-Derivate |
IT1224416B (it) * | 1987-12-24 | 1990-10-04 | Bracco Ind Chimica Spa | Chelanti macrociclici e loro chelati |
AU660033B2 (en) * | 1991-05-23 | 1995-06-08 | Imarx Pharmaceutical Corp. | Liposoluble compounds for magnetic resonance imaging |
US5358704A (en) * | 1993-09-30 | 1994-10-25 | Bristol-Myers Squibb | Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents |
-
1990
- 1990-03-19 DE DE4009119A patent/DE4009119A1/de not_active Withdrawn
-
1991
- 1991-03-18 CA CA002038493A patent/CA2038493C/fr not_active Expired - Lifetime
- 1991-03-18 NO NO911063A patent/NO179610C/no not_active IP Right Cessation
- 1991-03-18 HU HU91874A patent/HU215964B/hu active Protection Beyond IP Right Term
- 1991-03-18 EP EP91250081A patent/EP0448191B1/fr not_active Expired - Lifetime
- 1991-03-18 AT AT91250081T patent/ATE124405T1/de not_active IP Right Cessation
- 1991-03-18 JP JP3077058A patent/JP2968367B2/ja not_active Expired - Lifetime
- 1991-03-18 DE DE59105815T patent/DE59105815D1/de not_active Expired - Lifetime
- 1991-03-18 DK DK91250081.6T patent/DK0448191T3/da active
- 1991-03-18 ES ES91250081T patent/ES2074219T3/es not_active Expired - Lifetime
- 1991-03-18 PT PT97065A patent/PT97065B/pt not_active IP Right Cessation
- 1991-03-18 DE DE2000175007 patent/DE10075007I2/de active Active
- 1991-03-18 NZ NZ237461A patent/NZ237461A/en unknown
- 1991-03-19 FI FI911330A patent/FI109695B/fi active Protection Beyond IP Right Term
- 1991-03-19 US US07/671,041 patent/US5980864A/en not_active Expired - Lifetime
- 1991-03-19 IE IE90291A patent/IE67643B1/en not_active IP Right Cessation
- 1991-03-19 AU AU73610/91A patent/AU647091B2/en not_active Expired
- 1991-03-19 IL IL9759291A patent/IL97592A/en not_active IP Right Cessation
-
1998
- 1998-03-10 HK HK98101937A patent/HK1002811A1/xx not_active IP Right Cessation
-
1999
- 1999-07-23 US US09/359,045 patent/US6399043B1/en not_active Expired - Fee Related
-
2001
- 2001-02-14 NO NO2001003C patent/NO2001003I1/no unknown
-
2002
- 2002-04-09 US US10/118,430 patent/US6951639B2/en not_active Expired - Fee Related
-
2005
- 2005-09-26 US US11/234,385 patent/US20060078503A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0448191T3 (da) | 1,4,7,10-tetraazacyklododecan-butyltrioler, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende disse | |
DK0496378T3 (da) | Biphenylderivater, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling | |
NO914356D0 (no) | Mono n-substituerte 1,4,7,10-tetraazacyklododecan-derivater | |
FI96204C (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi | |
DK0624595T3 (da) | Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler | |
DK0624596T3 (da) | Tetrazolderivater af galdesyrer, fremgangsmåde tilderes fremstilling og anvendelse af disse forbindelser som lægemidler | |
NO891187L (no) | Meso-tetrafenylporfyrin-kompleksforbindelser, fremgangsmaate for fremstilling derav og farmasoeytiske midler som inneholder disse. | |
NO924433L (no) | Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse | |
DK0483667T3 (da) | Cykliske iminoderivater, lægemidler indholdende disse forbindelser og fremgangsmåde til fremstilling deraf | |
DK324286D0 (da) | 1-substituerede oxindol-3-carboxamider og deres anvendelse som antiinflammatoriske og analgetiske midler | |
DK0567966T3 (da) | Cykliske aminoderivater, fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser | |
PT83535B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos | |
DK0461986T3 (da) | Hexahydroazepinderivater, en fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse | |
PT86233A (fr) | Procede de preparation d:une variant de l:hirudine | |
DK444982A (da) | Substituerede hydroxymalonsyrediamider, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempende midler | |
EP0221493A3 (en) | Use of gyrase blocking agents in decontaminating cell cultures infested by mycoplasmas | |
DK0658557T3 (da) | Eburnan-derivater, fremgangsmåde til fremstilling af sådanne derivater og farmaceutiske sammensætninger indeholdende disse | |
NO882113L (no) | Substituerte vinylcefalosporiner, fremgangsmaate til deresfremstilling, og deres anvendelse som legemiddel. | |
DK467488D0 (da) | Benzo(b)phenanthridinderivater samt deres fremstilling og anvendelse | |
AU579997B2 (en) | Iminosulphonamides and processes for the manufacture thereof, pharmaceutical preparations containing such compounds, and their use |